Equities

Surgical Innovations Group PLC

SUN:LSE

Surgical Innovations Group PLC

Health CareMedical Equipment and Services
  • Price (GBX)0.550
  • Today's Change0.00 / 0.00%
  • Shares traded331.93k
  • 1 Year change-52.17%
  • Beta0.8254
Data delayed at least 15 minutes, as of Oct 04 2024 14:31 BST.
More ▼

Profile data is unavailable for this security.

About the company

Surgical Innovations Group Plc is a holding company that is involved in the design, manufacture, sale and distribution of quality medical products, primarily for use in minimally invasive surgery. In addition, the Company designs and develops medical devices for original equipment manufacturer (OEM) partners. The Company’s segments include SI Brand, OEM, and Distribution. The SI Brand segment is engaged in the research, development, manufacture, and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture, and distribution of minimally invasive devices for third party medical device companies through their own label or co-branding. It also includes research, development, manufacture, and sale of minimally invasive technology products for precision engineering applications. The Distribution segment is engaged in the distribution of specialist medical products sold by Elemental Healthcare Ltd.

  • Revenue in GBP (TTM)12.54m
  • Net income in GBP-622.00k
  • Incorporated1988
  • Employees101.00
  • Location
    Surgical Innovations Group PLCClayton Wood House, 6 Clayton Wood BankLEEDS LS16 6QZUnited KingdomGBR
  • Phone+44 11 3230 7597Fax+44 11 3230 7598
  • Websitehttps://www.sigroupplc.com/
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Deltex Medical Group plc1.78m-1.29m1.99m37.001.99m37.00
Image Scan Holdings Plc2.56m-11.06k3.76m14.003.76m14.00
Aptamer Group PLC1.04m-7.01m4.42m54.004.42m54.00
Surgical Innovations Group Plc12.54m-622.00k5.13m101.005.13m101.00
Feedback plc886.00k-3.49m5.47m24.005.47m24.00
Myhealthchecked PLC9.39m-1.04m6.90m10.006.90m10.00
Proteome Sciences plc4.04m-4.08m8.74m35.008.74m35.00
Cambridge Nutritional Sciences PLC9.77m-328.00k8.80m94.008.80m94.00
Rua Life Sciences PLC2.19m-1.44m9.00m33.009.00m33.00
Genincode PLC2.60m-5.94m9.29m36.009.29m36.00
Genedrive PLC272.00k-5.00m9.91m43.009.91m43.00
Renalytix PLC2.59m-35.24m13.70m80.0013.70m80.00
Data as of Oct 04 2024. Currency figures normalised to Surgical Innovations Group PLC's reporting currency: UK Pound GBX

Institutional shareholders

40.95%Per cent of shares held by top holders
HolderShares% Held
BGF Investment Management Ltd.as of 15 Mar 202470.73m7.58%
Healthinvest Partners ABas of 19 Apr 202467.93m7.28%
Stonehage Fleming Investment Management Ltd.as of 15 Mar 202458.09m6.23%
Ruffer LLPas of 17 Apr 202448.26m5.17%
Hargreaves Lansdown Asset Management Ltd.as of 15 Mar 202441.56m4.46%
Interactive Investor Services Ltd.as of 15 Mar 202433.70m3.61%
Investec Wealth & Investment Ltd.as of 01 Jul 202426.78m2.87%
Unicorn Asset Management Ltd.as of 01 Jul 202419.14m2.05%
IG Markets Ltd.as of 01 Jul 202410.71m1.15%
HSBC Global Asset Management (UK) Ltd.as of 01 Jul 20245.07m0.54%
More ▼
Data from 31 Mar 2024 - 01 Aug 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.